Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2023 Filed Mar 9, 2023 21:12 UTC |
KELLOGG PETER NDirector
|
GrantStock Option (right to buy) · Derivative | 4,948 | $0.00 Strike: $194.34 | $0.00 |
DisclosureSEC source: 0001735276-23-000036 · edgardoc.xml · derivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,948 Underlying: Common Stock · 4,948 shares Expires 2033-03-07 F1 · derivative.exercise_date: The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:07 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $96.45 | $0.00 |
DisclosureSEC source: 0001735276-23-000033 · edgardoc.xml · derivative · entry 7 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022. F4 · derivative.exercise_date: The stock option vested as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date, and were fully vested on December 17, 2018. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:07 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionPerformance Stock Option 2014 (right to buy) · Derivative | 2,500 | $0.00 Strike: $96.45 | $0.00 |
DisclosureSEC source: 0001735276-23-000033 · edgardoc.xml · derivative · entry 6 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:07 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
SaleCommon Stock | 18,072 | $200.00 | $3,614,400.00 |
DisclosureSEC source: 0001735276-23-000033 · edgardoc.xml · nonDerivative · entry 3 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,345 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:07 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionCommon Stock | 2,500 | $96.45 | $241,125.00 |
DisclosureSEC source: 0001735276-23-000033 · edgardoc.xml · nonDerivative · entry 2 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:07 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
Exercise / conversionCommon Stock | 2,500 | $96.45 | $241,125.00 |
DisclosureSEC source: 0001735276-23-000033 · edgardoc.xml · nonDerivative · entry 1 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:23 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 36,775 | $0.00 Strike: $190.01 | $0.00 |
DisclosureSEC source: 0001735276-23-000031 · edgardoc.xml · derivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,775 Underlying: Common Stock · 36,775 shares Expires 2033-02-27 F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance. F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:23 UTC |
Greenstreet YvonneDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 17,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000031 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,763 Underlying: Common Stock · 17,763 shares Expires 2026-02-27 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 35,525 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest. F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:22 UTC |
Vaishnaw AkshayPresident
|
GrantStock Option (right to buy) · Derivative | 11,986 | $0.00 Strike: $190.01 | $0.00 |
DisclosureSEC source: 0001735276-23-000030 · edgardoc.xml · derivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,986 Underlying: Common Stock · 11,986 shares Expires 2033-02-27 F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance. F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:22 UTC |
Vaishnaw AkshayPresident
|
GrantRestricted Stock Units · Derivative | 5,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000030 · edgardoc.xml · derivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,790 Underlying: Common Stock · 5,790 shares Expires 2026-02-27 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 11,579 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest. F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:22 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
GrantStock Option (right to buy) · Derivative | 11,850 | $0.00 Strike: $190.01 | $0.00 |
DisclosureSEC source: 0001735276-23-000029 · edgardoc.xml · derivative · entry 2 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,850 Underlying: Common Stock · 11,850 shares Expires 2033-02-27 F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance. F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:22 UTC |
Garg PushkalCMO & EVP Dev & Med Affairs
|
GrantRestricted Stock Units · Derivative | 5,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000029 · edgardoc.xml · derivative · entry 1 Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,724 Underlying: Common Stock · 5,724 shares Expires 2026-02-27 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 11,447 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest. F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:21 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 11,850 | $0.00 Strike: $190.01 | $0.00 |
DisclosureSEC source: 0001735276-23-000028 · edgardoc.xml · derivative · entry 2 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,850 Underlying: Common Stock · 11,850 shares Expires 2033-02-27 F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance. F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:21 UTC |
Poulton Jeffrey V.EVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 5,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000028 · edgardoc.xml · derivative · entry 1 Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,724 Underlying: Common Stock · 5,724 shares Expires 2026-02-27 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 11,447 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest. F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:21 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 10,352 | $0.00 Strike: $190.01 | $0.00 |
DisclosureSEC source: 0001735276-23-000027 · edgardoc.xml · derivative · entry 2 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,352 Underlying: Common Stock · 10,352 shares Expires 2033-02-27 F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance. F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:21 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000027 · edgardoc.xml · derivative · entry 1 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-02-27 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 10,000 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest. F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:21 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
GrantStock Option (right to buy) · Derivative | 5,449 | $0.00 Strike: $190.01 | $0.00 |
DisclosureSEC source: 0001735276-23-000026 · edgardoc.xml · derivative · entry 2 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,449 Underlying: Common Stock · 5,449 shares Expires 2033-02-27 F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance. F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:21 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
GrantRestricted Stock Units · Derivative | 2,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000026 · edgardoc.xml · derivative · entry 1 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,632 Underlying: Common Stock · 2,632 shares Expires 2026-02-27 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 5,263 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest. F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:13 UTC |
PYOTT DAVID E IDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000018 · edgardoc.xml · derivative · entry 3 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F3 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date. F3 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:13 UTC |
PYOTT DAVID E IDirector
|
Exercise / conversionCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000018 · edgardoc.xml · nonDerivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:13 UTC |
SCHULMAN AMY WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000019 · edgardoc.xml · derivative · entry 2 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date. F2 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:13 UTC |
SCHULMAN AMY WDirector
|
Exercise / conversionCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000019 · edgardoc.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:12 UTC |
HAMBURG MARGARET ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000017 · edgardoc.xml · derivative · entry 2 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date. F2 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:12 UTC |
HAMBURG MARGARET ADirector
|
Exercise / conversionCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000017 · edgardoc.xml · nonDerivative · entry 1 HAMBURG MARGARET A · CIK 0001266917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:11 UTC |
Fanucci MarshaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000016 · edgardoc.xml · derivative · entry 2 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F2 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date. F2 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:11 UTC |
Fanucci MarshaDirector
|
Exercise / conversionCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000016 · edgardoc.xml · nonDerivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:11 UTC |
Ausiello Dennis ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000015 · edgardoc.xml · derivative · entry 3 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F3 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date. F3 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:11 UTC |
Ausiello Dennis ADirector
|
Exercise / conversionCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000015 · edgardoc.xml · nonDerivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,913 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · derivative · entry 8 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,913 shares Expires 2023-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. F8 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
SaleCommon Stock | 4,302 | $217.05 | $933,749.10 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 6 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,970 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $216.96 to $217.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
SaleCommon Stock | 19,447 | $216.38 | $4,207,941.86 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 5 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,272 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $215.89 to $216.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
SaleCommon Stock | 10,279 | $215.59 | $2,216,049.61 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 4 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,719 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $214.88 to $215.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
SaleCommon Stock | 2,307 | $214.28 | $494,343.96 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 3 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,998 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $213.72 to $214.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
SaleCommon Stock | 1,709 | $213.13 | $364,239.17 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 2 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,305 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $212.71 to $213.70. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:03 UTC |
Vaishnaw AkshayPresident
|
Exercise / conversionCommon Stock | 30,913 | $63.00 | $1,947,519.00 |
DisclosureSEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 953 | $233.31 | $222,344.43 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 10 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022. F10 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $233.02 to $233.81. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,293 | $232.53 | $300,661.29 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 9 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 953 F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022. F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $231.94 to $232.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 865 | $231.35 | $200,117.75 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 8 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,246 F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022. F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $230.90 to $231.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 185 | $230.20 | $42,587.00 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 7 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,111 F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022. F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $229.87 to $230.62. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 128 | $227.68 | $29,143.04 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 6 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,296 F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022. F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $227.63 to $228.38. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:46 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
SaleCommon Stock | 5 | $227.38 | $1,136.90 |
DisclosureSEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 5 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:46 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
SaleCommon Stock | 586 | $226.62 | $132,799.32 |
DisclosureSEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 4 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,505 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:46 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
SaleCommon Stock | 1,007 | $225.80 | $227,380.60 |
DisclosureSEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 3 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,091 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:46 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
SaleCommon Stock | 77 | $223.97 | $17,245.69 |
DisclosureSEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 2 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,098 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 4 | $227.38 | $909.52 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 5 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,424 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 561 | $226.62 | $127,133.82 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 4 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,428 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 963 | $225.80 | $217,445.40 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 3 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,989 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:45 UTC |
Tanguler TolgaEVP, Chief Commercial Officer
|
SaleCommon Stock | 73 | $223.97 | $16,349.81 |
DisclosureSEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 2 Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952 F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:46 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 5,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000007 · edgardoc.xml · derivative · entry 6 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,350 Underlying: Common Stock · 5,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F6 · derivative.exercise_date: On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 1, 2023 the first third vested and released as reported on this Form 4. F6 · derivative.expiration_date: On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 1, 2023 the first third vested and released as reported on this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:46 UTC |
Franchini Indrani LallEVP, CLO & Secretary
|
Exercise / conversionCommon Stock | 5,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 1 Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.